Hong Kong Exchange (HKEX) to Launch Hang Seng Biotech Index Futures (28/11/25) Which Tracks Performance of 30 Largest Southbound Stock Connect-Eligible Biotech, Pharmaceuticals & Medical Devices Companies Listed In Hong Kong
15th October | Hong Kong
Hong Kong Exchange (HKEX) is launching the Hang Seng Biotech Index Futures (28/11/25), tracking the performance of 30 largest southbound Stock Connect-eligible biotech, pharmaceuticals and medical devices companies listed in Hong Kong. Announcement (14/10/25): “Hong Kong Exchanges and Clearing Limited (HKEX) is pleased to announce today (Tuesday) plans to launch Hang Seng Biotech Index Futures, the latest enhancement to its growing derivatives product ecosystem. The new futures contract, which commences trading on 28 November 2025, subject to regulatory approval, is based on the Hang Seng Biotech Index. The Hang Seng Biotech Index tracks the performance of the 30 largest southbound Stock Connect-eligible biotech, pharmaceuticals and medical devices companies listed in Hong Kong. The futures will offer investors with a targeted risk management tool for one of the fastest-growing and most dynamic sectors, complementing HKEX’s existing suite of biotech-related offerings and flagship equity index derivatives … … Since HKEX’s listing reforms in 2018, biotech and healthcare have emerged as one of the most active sectors in Hong Kong’s capital markets. Today, over 260 biotech and healthcare companies are listed on HKEX, representing a combined market capitalisation of over $4.8 trillion — up 400% from about $1.2 trillion at the end of 2018. Margin rates will be announced in due course. Additional information about the Hang Seng Biotech Index Futures is available on the circular published today.”
“ Hong Kong Exchange (HKEX) to Launch Hang Seng Biotech Index Futures (28/11/25) Which Tracks Performance of 30 Largest Southbound Stock Connect-Eligible Biotech, Pharmaceuticals & Medical Devices Companies Listed In Hong Kong “
![](https://www.caproasia.com/wp-content/uploads/2025/08/Air-Charter-Service-728x90-1.png")
HKEX Head of Markets, Gregory Yu: “Driven by innovation and strong global healthcare demand, the biotech industry is one of the most exciting frontiers in capital markets today. We are therefore pleased to launch the Hang Seng Biotech Index Futures, which expands investor access to the sector’s potential and provides a robust hedging tool, contributing to the development of the region’s biotech ecosystem. The introduction of this new futures product reinforces HKEX’s commitment to strengthening Hong Kong’s position as Asia’s leading derivatives trading and risk management centre, as we continue to progress our markets, adding breadth and diversity to meet the evolving needs of global investors.”
HKEX – Hong Kong Exchanges and Clearing Limited (HKEX) is a publicly-traded company (HKEX Stock Code: 388) and one of the world’s leading global exchange groups, offering a range of equity, derivative, commodity, fixed income and other financial markets, products and services, including the London Metal Exchange. As a superconnector and gateway between East and West, HKEX facilitates the two-way flow of capital, ideas and dialogue between China and the rest of the world, through its pioneering Connect schemes, increasingly diversified product ecosystem and its deep, liquid and international markets. HKEX is a purpose-led organisation which, across its business and through the work of HKEX Foundation, seeks to connect, promote and progress its markets and the communities it supports for the prosperity of all.
Hong Kong Exchange (HKEX) to Launch Hang Seng Biotech Index Futures (28/11/25) Which Tracks Performance of 30 Largest Southbound Stock Connect-Eligible Biotech, Pharmaceuticals & Medical Devices Companies Listed In Hong Kong
Caproasia Users
- Manage $20 million to $30 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2026 Investment Day
- March - Hong Kong
- March - Singapore
- April - Hong Kong
- April - Singapore
- July - Hong Kong
- July - Singapore
- Sept- Hong Kong
- Sept - Singapore
- Oct- Hong Kong
- Nov - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit
